Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
Friday, January 10, 2025
Comment
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.
from Personal Finance https://ift.tt/gxfiQEk
from Personal Finance https://ift.tt/gxfiQEk
0 Response to "Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds"
Post a Comment